NVNO
Price
$2.69
Change
-$0.38 (-12.38%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
72.44M
55 days until earnings call
WAT
Price
$390.15
Change
-$2.84 (-0.72%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
20.38B
56 days until earnings call
Ad is loading...

NVNO vs WAT

Header iconNVNO vs WAT Comparison
Open Charts NVNO vs WATBanner chart's image
enVVeno Medical
Price$2.69
Change-$0.38 (-12.38%)
Volume$683
Capitalization72.44M
Waters
Price$390.15
Change-$2.84 (-0.72%)
Volume$2.21K
Capitalization20.38B
NVNO vs WAT Comparison Chart
Loading...
NVNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVNO vs. WAT commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVNO is a Hold and WAT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (NVNO: $3.07 vs. WAT: $392.99)
Brand notoriety: NVNO and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVNO: 58% vs. WAT: 105%
Market capitalization -- NVNO: $72.44M vs. WAT: $20.38B
NVNO [@Medical Specialties] is valued at $72.44M. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVNO’s FA Score shows that 1 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • NVNO’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, WAT is a better buy in the long-term than NVNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVNO’s TA Score shows that 1 TA indicator(s) are bullish while WAT’s TA Score has 5 bullish TA indicator(s).

  • NVNO’s TA Score: 1 bullish, 8 bearish.
  • WAT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, WAT is a better buy in the short-term than NVNO.

Price Growth

NVNO (@Medical Specialties) experienced а -3.46% price change this week, while WAT (@Medical Specialties) price change was +4.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.36%. For the same industry, the average monthly price growth was -7.61%, and the average quarterly price growth was -4.31%.

Reported Earning Dates

NVNO is expected to report earnings on May 05, 2025.

WAT is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (-2.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAT($20.4B) has a higher market cap than NVNO($72.4M). WAT YTD gains are higher at: 5.933 vs. NVNO (1.656). WAT has higher annual earnings (EBITDA): 1B vs. NVNO (-24.69M). WAT has more cash in the bank: 396M vs. NVNO (46.4M). NVNO has less debt than WAT: NVNO (1.4M) vs WAT (2.44B). WAT has higher revenues than NVNO: WAT (2.96B) vs NVNO (0).
NVNOWATNVNO / WAT
Capitalization72.4M20.4B0%
EBITDA-24.69M1B-2%
Gain YTD1.6565.93328%
P/E RatioN/A31.78-
Revenue02.96B-
Total Cash46.4M396M12%
Total Debt1.4M2.44B0%
FUNDAMENTALS RATINGS
NVNO vs WAT: Fundamental Ratings
NVNO
WAT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10035
SMR RATING
1..100
9520
PRICE GROWTH RATING
1..100
8049
P/E GROWTH RATING
1..100
10036
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVNO's Valuation (31) in the null industry is somewhat better than the same rating for WAT (81) in the Medical Specialties industry. This means that NVNO’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (35) in the Medical Specialties industry is somewhat better than the same rating for NVNO (100) in the null industry. This means that WAT’s stock grew somewhat faster than NVNO’s over the last 12 months.

WAT's SMR Rating (20) in the Medical Specialties industry is significantly better than the same rating for NVNO (95) in the null industry. This means that WAT’s stock grew significantly faster than NVNO’s over the last 12 months.

WAT's Price Growth Rating (49) in the Medical Specialties industry is in the same range as NVNO (80) in the null industry. This means that WAT’s stock grew similarly to NVNO’s over the last 12 months.

WAT's P/E Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for NVNO (100) in the null industry. This means that WAT’s stock grew somewhat faster than NVNO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVNOWAT
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
61%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
60%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 7 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
58%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
44%
View a ticker or compare two or three
Ad is loading...
NVNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYPR0.980.02
+2.40%
Hyperfine
XOM109.021.40
+1.30%
Exxon Mobil Corp
SUPN32.070.25
+0.79%
Supernus Pharmaceuticals
MASI174.52-1.09
-0.62%
Masimo Corp
STOK8.01-0.14
-1.72%
Stoke Therapeutics

NVNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVNO has been loosely correlated with CUTR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NVNO jumps, then CUTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVNO
1D Price
Change %
NVNO100%
+2.33%
CUTR - NVNO
33%
Loosely correlated
-15.75%
INBS - NVNO
28%
Poorly correlated
+4.31%
WAT - NVNO
27%
Poorly correlated
+1.72%
CHEK - NVNO
27%
Poorly correlated
+3.02%
GENE - NVNO
25%
Poorly correlated
N/A
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been closely correlated with A. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
+1.72%
A - WAT
76%
Closely correlated
+0.12%
MTD - WAT
75%
Closely correlated
+1.49%
TMO - WAT
58%
Loosely correlated
+0.77%
BRKR - WAT
58%
Loosely correlated
+0.44%
RVTY - WAT
56%
Loosely correlated
+3.84%
More